Good Clinical Trials Collaborative is running a survey to understand the impact of the pandemic on randomised clinical trials and in the experiences of those working on clinical trials over these past 6 months. For some those trials will be specifically addressing COVID-19, and for many more, the impact has been on trials in other areas of health and treatment of disease.
- What practices have had to change?
- What practices have changed for the better?
- What can we learn from those changes that might inform the way that we conduct clinical trials in the future?
Good Clinical Trials Collaborative wants to capture those lessons and take them forwards. So please share your experiences, your innovations, and the lessons you have learned, the survey should take no longer than 15 minutes to complete.
About the Good Clinical Trials Collaborative
The Good Clinical Trials Collaborative has been established to develop and promote the adoption of new Good Clinical Trial guidelines, based on ethical and scientific principles of randomised controled trials. This initiative is supported by the Wellcome Trust, the Bill & Melinda Gates Foundation, and the African Academy of Science. We work across all communities, sectors, and professions involved in clinical trials, and with patients whose care and whose health depends on the results.